Encapsulation of immunoadjuvant [14C]peptidoglycan monomer into liposomes. Effect on metabolism and immune response in mice.
14C-labeled peptidoglycan monomer was encapsulated into negatively charged, multilamellar liposomes composed of egg phosphatidylcholine, cholesterol and dicetylphosphate. Excretion and tissue distribution of the label in mice were studied after intravenous injections. Encapsulation of peptidoglycan monomer into liposomes as compared to free peptidoglycan monomer, resulted in increased retention of the label, particularly in the liver and to a lesser extent in spleen. The excretion was drastically reduced and delayed even after 4 days when cholesterol-rich (phosphatidylcholine/cholesterol, 7:5 molar ratio) liposomes were used for encapsulation of peptidoglycan monomer. Peptidoglycan monomer and liposomes, when tested separately, stimulate the immune response to sheep erythrocytes in mice. However, there was no significant additive or synergistic effect when peptidoglycan monomer was encapsulated into liposomes.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D008081:Liposomes / Q000276:immunology*; D008099:Liver / Q000378:metabolism; D051379:Mice; D008808:Mice, Inbred CBA; D010457:Peptidoglycan / Q000276:immunology* / Q000494:pharmacology; D012756:Sheep; D013154:Spleen / Q000378:metabolism; D014018:Tissue Distribution
D008081:Liposomes; D010457:Peptidoglycan